🔗 Share this article

An underground economy for unlicensed slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Investigational Treatment Gaining Traction Via Social Media

Retatrutide, which is still in research studies, is being advertised by social media influencers for its supposed fat-burning effects. Viewers are encouraged to contact these accounts directly for supplier links, while also obtaining promotional offers.

Active Commerce on Social Networks

Separately, a flourishing trade exists on Telegram, where groups with numerous of members share comparison photos, injection guides and assertions of rapid UK delivery. Vendors market the drug there before directing buyers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Express Worries

Nevertheless, doctors and pharmacists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is worrisome and could lead to users injecting substances of uncertain source.

Some professionals said the popularity for retatrutide could be linked to the rising cost of approved slimming treatments such as Mounjaro.

Regulatory Position and Implementation

Marketing retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unapproved drug that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still violate medicines, advertising, and consumer regulations, risking fines, prosecution or prison.

Platform Reaction and Material Elimination

Based on the social media company, the platform has removed problematic material and prohibited associated hashtags and query recommendations. The company stated it was committed to maintaining the service secure and investing in enhancing enforcement strategies.

Digital Trading Operations

Investigations also discovered communities with up to 9,000 members selling retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays channels with thousands of members, populated with photos of weight loss, glowing testimonials and detailed instructions for mixing or administering at home.

After minutes of entering one community, a vendor shared contact information, where most purchases take place. The vendor provided an instruction manual and guaranteed shipping within two days. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None inquired about weight, health issues or previous experience.

Item Information and Costs

Inside these groups, messages display black plastic packages with postal service labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at residence with sterile water, or ready-to-use injectors typically sold at 160 pounds for 20mg. When questioned how long a injector should last, sellers give contradictory answers varying between a several days to “depends on your body”.

Platform Moderation and Security Actions

A spokesperson for the messaging service said it regularly monitored dangerous material on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are administering substances they cannot confirm. Although the science behind this drug is sound, these digital products may not include what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, patients are turning to online platforms. But counterfeit treatments are highly dangerous. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she said.

Her team has previously seen patients injured by self-injection from unverified sources. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your health,” said the doctor. “These materials could be contaminated or improperly measured.”

Producer Statement

A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a company experimental product not yet authorized … may subject users to potentially serious medical dangers”.